mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.06 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.07 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.08 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.08 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |